Sort
78,016 grants matching “breast cancer”
Estrogen and Its Receptors in Angiogenesis
$439,066Charlotte Kuperwasser · Beth Israel Deaconess Medical Center · P01 · FY2011 · CA
Methylation of the Calcitonin Gene in Human Tumors
$439,060Stephen B Baylin · Johns Hopkins University · R01 · FY2006 · CA
EPIGENETIC SUBTYPES OF TRIPLE NEGATIVE BREAST CANCER
$439,045President And Fellows Of Harvard College · · FY2014 · Department of the Army
SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNG TUMOR RECURRENCE
$439,002Mark W Grinstaff · Boston University (Charles River Campus) · R01 · FY2020 · CA
ANNEXIN II-DEPENDENT MECHANISM OF BREAST CANCER PROGRESSION
$438,995Institute For Clinical Research, Inc · · FY2008 · Department of Defense
The Mechanism and Therapeutic Potential of Targeting the Ninjurin Pathway for Tumors Carrying Wild-Type p53
$438,940Xinbin Chen · University Of California At Davis · R01 · FY2022 · CA
Imaging Habitats in Sarcoma
$438,929Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2016 · CA
Imaging Habitats in Sarcoma
$438,929Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2015 · CA
Molecular basis and evolution of complex trait variation with significance in human health
$438,926Bao-Hua Song · University Of North Carolina Charlotte · R15 · FY2016 · GM
INTERNET DECISION SUPPORT FOR BRCA1/BRCA2 CARRIERS
$438,917Marc D Schwartz · Georgetown University · R01 · FY2010 · CA
SIGNAL TRANSDUCTION BY ERBB2/ERBB3 OLIGOMERS
$438,912Linda Joy Pike · Washington University · R01 · FY2015 · GM
SIGNAL TRANSDUCTION BY ERBB2/ERBB3 OLIGOMERS
$438,912Linda Joy Pike · Washington University · R01 · FY2016 · GM
SIGNAL TRANSDUCTION BY ERBB2/ERBB3 OLIGOMERS
$438,912Linda Joy Pike · Washington University · R01 · FY2017 · GM
Deguelin in therapy of triple negative breast cancer
$438,848Rajendra G Mehta · Iit Research Institute · R01 · FY2013 · CA
Collagen remodeling and tumor progression
$438,845Valerie Marie Weaver · University Of California, San Francisco · R01 · FY2010 · CA
Gene Expression in Cancer by Microarray Hybridization
$438,826Patrick O. Brown · Stanford University · R01 · FY2007 · CA
INNOVATIVE MICROSYSTEMS:NOVEL NANOSTRUCTURES TO CAPTURE CIRCULATING BREAST CANCER CELLS
$438,826University Of Arizona · · FY2008 · Department of Defense
Cyst-X: Interpretable Deep Learning Based Risk Stratification of Pancreatic Cystic Tumors
$438,819Ulas Bagci · Northwestern University At Chicago · R01 · FY2021 · CA
Viscotaxis: Novel cell migration mechanisms regulated by microenvironmental viscosity
$438,793Konstantinos Konstantopoulos · Johns Hopkins University · R01 · FY2024 · CA
Control of Protein Synthesis by the UPS Under Stress
$438,726Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · CA
Control of Protein Synthesis by the UPS Under Stress
$438,726Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2018 · CA
Mechanism of beta-Catenin and APC-Regulated Transcription at Wnt Target Genes
$438,719Katherine A Jones · Salk Institute For Biological Studies · R01 · FY2014 · CA
Cognitive Functioning After Breast Cancer Treatment
$438,696Patricia A. Ganz · University Of California Los Angeles · R01 · FY2010 · CA
NANOENGINEERED DRUG COMBINATIONS FOR BREAST CANCER TREATMENT
$438,686University Of California, Santa Barbara · · FY2011 · Department of the Army
Prevalence effects in visual search: Theoretical and practical implications
$438,668Jeremy M Wolfe · Brigham And Women'S Hospital · R01 · FY2012 · EY